REGEN
Get REGENGet Now
LibraryToolsNotesBlogFAQ

SLU-PP-332 Stacking and Combinations

Which compounds SLU-PP-332 is paired with, and the rationale behind each combination.

RE
Compiled from published research · Last updated 2026-08-18T00:00:00.000Z

SLU-PP-332 + SLU-PP-915

SLU-PP-332 is sometimes discussed alongside its orally-active successor compound SLU-PP-915 in research contexts, though they're typically used as alternatives (injectable vs. oral) rather than combined — both target the same ERR pathway.

Commonly paired with

  • SLU-PP-915 — The first orally-active pan-ERR agonist — raised exercise capacity in mice even when dosed orally, where its predecessor SLU-PP-332 needed injection.

References

  1. SLU-PP-332 pan-ERR agonist metabolic syndrome study · Billon C, et al. · 2024
All SLU-PP-332 sections

SLU-PP-915

longevity & healthspanDgrade

The first orally-active pan-ERR agonist — raised exercise capacity in mice even when dosed orally, where its predecessor SLU-PP-332 needed injection.

Thymosin Alpha-1

longevity & healthspanAgrade

A 28-amino-acid thymic peptide approved in 35+ countries as Zadaxin for immune support — but never FDA-approved in the United States.

Oxytocin

longevity & healthspanBgrade

A naturally occurring nonapeptide — FDA-approved as Pitocin for labor, and separately studied off-label (intranasal) for social bonding and stress research.

Put the whole protocol
in one place.

Download nowGet Now